Circulation Journal
Online ISSN : 1347-4820
Print ISSN : 1346-9843
ISSN-L : 1346-9843
Clinical Investigation
Limited Sampling Strategy for Mycophenolic Acid in Japanese Heart Transplant Recipients
Comparison of Cyclosporin and Tacrolimus Treatment
Kyoichi WadaMitsutaka TakadaTakeshi KotakeHiroyuki OchiHideki MorishitaKazuo KomamuraNoboru OdaAkiko ManoTomoko S. KatoAkihisa HanataniTakeshi Nakatani
Author information
JOURNAL FREE ACCESS

2007 Volume 71 Issue 7 Pages 1022-1028

Details
Abstract

Background The purpose of the study was to characterize the pharmacokinetics of mycophenolic acid (MPA) in Japanese heart transplant recipients and to find the time point that has the best correlation with the MPA area under the plasma concentration curve (AUC). Methods and Results Twenty-two Japanese recipients treated with mycophenolate mofetil were evaluated in the study. Approximately 9 months after transplantation, the area under the MPA serum concentration-time curve from 0 to 12 h (AUC0-12 h) was evaluated. The MPA AUC0-12 h h values in the cyclosporine (CsA) and tacrolimus (FK) groups ranged from 13.11 to 50.98 μg · h/ml and from 39.19 to 93.18 μg · h/ml, respectively. Fourteen models were developed and analyzed for their ability to estimate the MPA AUC0-12 h based on a limited number of samples in the CsA group. Sixteen models were developed in the FK group. The best model for predicting the full MPA AUC0-12 h in the CsA group was a 3-time-point model that included C0 h, C1 h and C2 h (r2, 0.96; mean prediction error, 0.15±7.85%); a 2-time-point model that included C0 h, and C2 h (r2, 0.94; mean prediction error, 0.495±10.35%) was also reliable. In the FK group, a 3-time-point model that included C1 h, C2 h and C4h (r2, 0.73; mean prediction error, 2.73±17.09%) was the best model for predicting the full MPA AUC0-12 h, but it was not reliable in clinical practice. Conclusion A 3-(C0 h, C1 h and C2 h) and a 2-time-point model (C0 h and C2 h) are useful for predicting the full MPA AUC0-12 h in Japanese heart transplant recipients treated with CsA but not with FK. (Circ J 2007; 71: 1022 - 1028)

Content from these authors
© 2007 THE JAPANESE CIRCULATION SOCIETY
Previous article Next article
feedback
Top